Chemokinostatin-5

General Information


DRACP ID  DRACP02511

Peptide Name   Chemokinostatin-5

Sequence  NGKEICLDPEAPFLKKVIQKILD

Sequence Length  23

UniProt ID  P42830 

PubChem CID  Not available

Origin  Homo sapiens (CXCL5/ENA-78)

Type  Native peptide

Classification

  

Active ACP Cancer targeted peptides Antiangiogenic



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  CXCR

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02511

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C119H199N29O34S

Absent amino acids  HMRSTWY

Common amino acids  K

Mass  300474

Pl  6.45

Basic residues  4

Acidic residues  4

Hydrophobic residues  9

Net charge  0

Boman Index  -2487

Hydrophobicity  -17.39

Aliphatic Index  118.7

Half Life 
  Mammalian: 1.4 hour
  Yeast: 3 min
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 18307172

Title  Novel anti-angiogenic peptides derived from ELR-containing CXC chemokines

Doi 10.1002/jcb.21712

Year  2008

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.